Literature DB >> 23443954

Cardiac sympathetic denervation is not related to nigrostriatal degeneration in Parkinson's disease.

Agostino Chiaravalloti1, Alessandro Stefani, Daniele Di Biagio, Mariangela Pierantozzi, Mario Tavolozza, Barbara Di Pietro, Paolo Stanzione, Orazio Schillaci.   

Abstract

AIM: The aim of our study was to investigate the relationship between myocardial sympathetic degeneration and nigrostriatal impairment in patients affected by Parkinson's disease (PD) by means of (123)I-metaiodobenzylguanidine ((123)I MIBG) scintigraphy and N-(3-fluoropropyl)-2β-carbomethoxy-3β-(4-[(123)I]iodophenyl)nortropane ((123)I FP-CIT) scintigraphy. PATIENTS AND METHODS: The study involved 37 patients with clinical diagnosis of PD (22 males and 15 females, mean age 62 years (±10), evaluated with (123)I FP-CIT single photon emission computed tomography (SPECT) followed by (123)I MIBG scintigraphy within 20 (±3) days. Early and delayed anterior chest images were acquired and the heart/mediastinum ratio (H/M ratio) was calculated. Furthermore, the population has been divided on the basis of the main clinical pattern to investigate the possible role of a tremor-dominant or an akinetic-dominant phenotype in this comparison.
RESULTS: In PD population, there were no statistical relationships between early and delayed (123)I MIBG cardiac and (123)I FP-CIT striatal uptake in contralateral caudate (P > 0.05) and in contralateral putamen (P > 0.05) to the side mainly affected; no statistically significant relationships have been found at any level when considering ipsilateral striatum. We did not find statistically significant relationships when considering the single PD phenotypes.
CONCLUSIONS: The results of our study suggest that cardiac sympathetic system and nigrostriatal system are differently affected in PD. In particular, the sympathetic neurodegeneration rate is not related to nigrostriatal degeneration rate and vice versa in our series as detectable scintigraphically.

Entities:  

Mesh:

Year:  2013        PMID: 23443954     DOI: 10.1007/s12149-013-0702-z

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  8 in total

1.  Central Aortic Pressure and Arterial Stiffness in Parkinson's Disease: A Comparative Study.

Authors:  Mehmet Balal; Meltem Demirkiran; Saime Paydas
Journal:  Parkinsons Dis       Date:  2022-07-12

2.  Intrasubject relationship between striatal 18F-FP-CIT uptake and cardiac 123I-MIBG uptake differs by motor subtype in early Parkinson disease.

Authors:  Wooyoung Jang; Ji Young Lee; Ji Young Kim; Soo Jin Lee; Tae Yoon Kim; Yun Young Choi; Hee-Tae Kim; Chun K Kim
Journal:  Medicine (Baltimore)       Date:  2021-08-20       Impact factor: 1.817

3.  Do CSF levels of t-Tau, p-Tau and β₁₋₄₂ amyloid correlate with dopaminergic system impairment in patients with a clinical diagnosis of Parkinson disease? A ¹²³I-FP-CIT study in the early stages of the disease.

Authors:  Agostino Chiaravalloti; Alessandro Stefani; Alessandro Fiorentini; Annamaria Lacanfora; Paolo Stanzione; Orazio Schillaci
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-07-10       Impact factor: 9.236

4.  Assessment of myocardial sympathetic innervation with 18F-FDOPA-PET/CT in patients with autonomic dysfunction: feasibility study in IPD patients.

Authors:  Harish Goyal; Anshul Sharma; Chetan Patel; K K Deepak; Madhavi Tripathi; Priyanka Gupta; Rajeev Kumar; Chandra Shekhar Bal; Vinay Goyal
Journal:  J Nucl Cardiol       Date:  2021-01-10       Impact factor: 3.872

5.  Assessment of myocardial sympathetic innervation with 18F-FDOPA-PET/CT in patients with autonomic dysfunction: Feasibility study in IPD patients.

Authors:  Pamela K Woodard
Journal:  J Nucl Cardiol       Date:  2021-03-09       Impact factor: 3.872

6.  On the Utility of MIBG SPECT/CT in Evaluating Cardiac Sympathetic Dysfunction in Lewy Body Diseases.

Authors:  Hayato Odagiri; Toru Baba; Yoshiyuki Nishio; Osamu Iizuka; Minoru Matsuda; Kentaro Inoue; Akio Kikuchi; Takafumi Hasegawa; Masashi Aoki; Atsushi Takeda; Yasuyuki Taki; Etsuro Mori
Journal:  PLoS One       Date:  2016-04-07       Impact factor: 3.240

7.  Relationship between the washout rate of I-123 MIBG scans and autonomic function in Parkinson's disease.

Authors:  Young Jin Jeong; Ji-Eun Jeong; Sang-Myung Cheon; Byeol-A Yoon; Jae Woo Kim; Do-Young Kang
Journal:  PLoS One       Date:  2020-03-05       Impact factor: 3.240

8.  Importance of (123)I-ioflupane SPECT and Myocardial MIBG Scintigraphy to Determine the Candidate of Deep Brain Stimulation for Parkinson's Disease.

Authors:  Takashi Asahi; Daina Kashiwazaki; Tatsuya Yoneyama; Kyo Noguchi; Satoshi Kuroda
Journal:  Neurol Med Chir (Tokyo)       Date:  2016-01-20       Impact factor: 1.742

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.